About this trial
This study aims to compare intranasal dexmedetomidine versus intranasal ketamine as a premedication in children undergoing surgery in our population. Hypothesis is Intranal dexmedetomidine is better than intranasal ketamine in producing preoperative sedation in pediatric patients undergoing surgery under general anesthesia.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
American society of Anesthesiologist (ASA) class-I and II
Children 2-6 years of age undergoing elective surgery
Disqualifiers
Known hypersensitivity to study drugs
Refusal of consent
Known renal, hepatic or cardiac dysfunction
Nasal deformity or pathology
Trial design
Parallel
Treatments tested in this trial
Intranasal dexmedetomidine
Drugintranasal dexmedetomidine 2mcg/kg
Intranasal ketamine
Drugintranasal ketamine 2mg/kg
Treatment groups
Trial outcomes
Primary outcomes
Sedation score as assessed by MOAA/S
Modified Observer's Assessment of Alertness/ Sedation scale (MOAA/S): 6 = Appears alert and awake, responds readily to name spoken in a normal tone 5 = Appears asleep but responds readily to name spoken in a normal tone 4 = Lethargic response to name spoken in a normal tone 3 = Responds only after the name is called loudly or repeatedly 2 = Responds only after mild prodding or shaking 1 = Does not respond to mild prodding or shaking
Secondary outcomes
Ease of parental separation using PSAS
Parental Separation Anxiety Score (PSAS): 1. = Excellent (unafraid, cooperative) 2. = Good (slight fear or crying, easily reassured) 3. = Fair (moderate fear, not quiet with reassurance) 4. = Poor (crying, needing restraint)
Incidence of hypotension and bradycardia in the two groups
Intraoperative hypotension and bradycardia will be monitored before induction then every 5 minutes till the end of surgery or a maximum of 1 hour in the operating room.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: